A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects With Refractory Focal Onset Epilepsy
A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects With Refractory Focal Onset Epilepsy
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
This study has two parts, Part A and Part B. Part A is randomized 1:1:1 25 mg of BHV-7000, 50 mg of BHV-7000 or matching placebo. Part B is randomized 1:1 75mg BHV-7000 or matching placebo. Part B will start after Part A.
Key Inclusion Criteria:
Male and Female participants 18 to 75 years of age at time of consent.
Diagnosis of Focal Onset Epilepsy at least 1 year prior to screening visit defined by 2017 International League Against Epilepsy (ILAE) Classification and based on requirements of Epilepsy Adjudication criteria.
a. Focal seizures i. Focal aware seizures with clinically observable signs and/or symptoms ii. Focal impaired awareness seizures iii. Focal to bilateral tonic-clonic seizures
Subject meets the 2009 ILAE definition of drug resistant epilepsy, failure of adequate trials of two tolerated and appropriately chosen and used anti-seizure medication (ASM) schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom.
Ability to keep accurate seizure diaries
Current treatment with at least 1 and up to 3 ASMs and 4 epilepsy treatments in total
Key Exclusion Criteria:
clinicaltrials@biohavenpharma.com203-404-0410
Phoenix, Arizona 85013, United States
Caitlin.Goodman@CommonSpirit.org602-406-6262
New Haven, Connecticut 06519, United States
Ciudad Autónoma de Buenos Aires, Buenos Aires C1013AAB, Argentina
Balvanera, Ciudad Autónoma de BuenosAires C1221ADC, Argentina
Buenos Aires, Ciudad Autónoma de BuenosAires C1431FWO, Argentina
Buenos Aires, Ciudad Autónoma de BuenosAires C1437JCH, Argentina
San Miguel de Tucumán, Tucumán Province T4000AXL, Argentina
Buenos Aires, C1428AQK, Argentina
Santiago, Región-MetropolitanadeSantiago 8320000, Chile
Zagreb, City of Zagreb 10000, Croatia
Toulouse, Haute-Garonne 31059, France
Debrecen, Hajdú-Bihar 4031, Hungary
Heemstede, North Holland 2103 SW, Netherlands
Zwolle, Overijssel 8025 BV, Netherlands
Poznan, Greater Poland Voivodeship 60-702, Poland
Nowa Sól, Lubusz Voivodeship 67-100, Poland
Gdansk, Pomeranian Voivodeship 80-546, Poland
Rphillips@neurotucson.com520-795-0229
mafranks@clinicaltrialsinc.com501-227-6179
jor010@health.ucsd.edu
SWaghmare@mednet.ucla.edu310-794-1195
jseliger@stanford.edu650-460-9260
christopher.mizenko@cuanschutz.edu720-848-8621
showkat.hossain@novaclinicalresearch.com941-792-6564
yasmeen.shabbir@jax.ufl.edu904-244-9856
axc1623@med.miami.edu305-243-6732
mvasconcelos@medsolcrc.com941-623-9744
santosresearchcenter@gmail.com813-249-9100
abarreiro@encoremedicalresearch.com954-777-8827
ctscto@augusta.edu706-721-9680
kliow@hawaiineuroscience.com808-564-6141
Lisa@Idahoepilepsy.com208-275-8585 ext. 6
elizabeth.bachman@nm.org312-926-6562
morgan.medley@commonspirit.org859-313-4989
hashmis@epilepsydc.com301-530-9744
sellis@mnepilepsy.net651-377-8319
patty.schaefer@wustl.edu314-362-7871
hrana@epilepsygroup.com551-497-5000
mmalik@inst-neuro.com973-322-7425
hpearson@dentinstitute.com716-250-7002
dzogejan@nymc.edu914-768-8225
relsaadany@northwell.edu201-988-6177
Christiana.Pol@stonybrookmedicine.edu631-444-9083
egarcia@ftniresearch.com516-239-1800 ext. 135
cwhedric@wakehealth.edu336-716-8694
shandellm@neurocarecenter.com330-244-2542
Lucy.Mendoza@uc.edu513-558-3020
elizabeth.wiley@osumc.edu614-293-3660
melissa.johnstonesparza@pennmedicine.upenn.edu215-614-0520
emily.patunas@jefferson.edu215-503-3213
melissa.osborn@vumc.org615-322-8817
jchowell@neurologydallas.com214-750-9977 ext. 293
JHILL@TARRANTNEUROLOGY.COM817-336-3968
Lewiss11@uthscsa.edu210-450-7370
lsantana@rrresearchsa.com210-949-0505
austin.strebel@hsc.utah.edu801-585-9266
src2h@uvahealth.org434-982-4315
Gwendolyn.Darby@HCAHealthcare.com804-288-2742
kecooper1@carilionclinic.org540-224-5856